Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 677

1.

Facile target validation in an animal model with intracellularly expressed monobodies.

Gupta A, Xu J, Lee S, Tsai ST, Zhou B, Kurosawa K, Werner MS, Koide A, Ruthenburg AJ, Dou Y, Koide S.

Nat Chem Biol. 2018 Jul 16. doi: 10.1038/s41589-018-0099-z. [Epub ahead of print]

PMID:
30013062
2.

A CLC-type F-/H+ antiporter in ion-swapped conformations.

Last NB, Stockbridge RB, Wilson AE, Shane T, Kolmakova-Partensky L, Koide A, Koide S, Miller C.

Nat Struct Mol Biol. 2018 Jul;25(7):601-606. doi: 10.1038/s41594-018-0082-0. Epub 2018 Jun 25.

PMID:
29941917
3.

Impact of statin-ezetimibe combination on coronary atheroma plaque in patients with and without chronic kidney disease - Sub-analysis of PRECISE-IVUS trial.

Fujisue K, Nagamatsu S, Shimomura H, Yamashita T, Nakao K, Nakamura S, Ishihara M, Matsui K, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Sakamoto K, Izumiya Y, Kaikita K, Hokimoto S, Ogawa H, Tsujita K.

Int J Cardiol. 2018 Jun 18. pii: S0167-5273(18)30338-3. doi: 10.1016/j.ijcard.2018.04.051. [Epub ahead of print]

PMID:
29925472
4.

Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort study in Aichi, Japan.

Inaguma D, Ito E, Takahashi K, Hayashi H, Koide S, Hasegawa M, Yuzawa Y; AICOPP Group.

Clin Exp Nephrol. 2018 Jun 7. doi: 10.1007/s10157-018-1592-0. [Epub ahead of print]

PMID:
29882111
5.

Monobody-Mediated Alteration of Lipase Substrate Specificity.

Tanaka SI, Takahashi T, Koide A, Iwamoto R, Koikeda S, Koide S.

ACS Chem Biol. 2018 Jun 15;13(6):1487-1492. doi: 10.1021/acschembio.8b00384. Epub 2018 May 18.

PMID:
29757606
6.

Next-generation antibodies for post-translational modifications.

Hattori T, Koide S.

Curr Opin Struct Biol. 2018 May 9;51:141-148. doi: 10.1016/j.sbi.2018.04.006. [Epub ahead of print] Review.

PMID:
29753204
7.

Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method.

Ito E, Inaguma D, Koide S, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y.

Clin Exp Nephrol. 2018 May 10. doi: 10.1007/s10157-018-1584-0. [Epub ahead of print]

PMID:
29748907
8.

Hematopoietic insults damage bone marrow niche by activating p53 in vascular endothelial cells.

Si S, Nakajima-Takagi Y, Iga T, Tsuji M, Hou L, Oshima M, Koide S, Saraya A, Yamazaki S, Takubo K, Kubota Y, Minamino T, Iwama A.

Exp Hematol. 2018 Jul;63:41-51.e1. doi: 10.1016/j.exphem.2018.04.006. Epub 2018 Apr 27.

PMID:
29709619
9.

An Overlapping Region between the Two Terminal Folding Units of the Outer Surface Protein A (OspA) Controls Its Folding Behavior.

Makabe K, Nakamura T, Dhar D, Ikura T, Koide S, Kuwajima K.

J Mol Biol. 2018 Jun 8;430(12):1799-1813. doi: 10.1016/j.jmb.2018.04.025. Epub 2018 Apr 27.

PMID:
29709572
10.

Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis.

Inaguma D, Sasakawa Y, Suzuki N, Ito E, Takahashi K, Hayashi H, Koide S, Hasegawa M, Yuzawa Y; Tokai Aortic Stenosis in Dialysis Patients Cohort Study Group.

BMC Nephrol. 2018 Apr 3;19(1):80. doi: 10.1186/s12882-018-0877-6.

11.

Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme.

Zhang Z, Liang WG, Bailey LJ, Tan YZ, Wei H, Wang A, Farcasanu M, Woods VA, McCord LA, Lee D, Shang W, Deprez-Poulain R, Deprez B, Liu DR, Koide A, Koide S, Kossiakoff AA, Li S, Carragher B, Potter CS, Tang WJ.

Elife. 2018 Mar 29;7. pii: e33572. doi: 10.7554/eLife.33572.

12.

Muscle hypertrophy following blood flow-restricted, low-force isometric electrical stimulation in rat tibialis anterior: role for muscle hypoxia.

Nakajima T, Koide S, Yasuda T, Hasegawa T, Yamasoba T, Obi S, Toyoda S, Nakamura F, Inoue T, Poole DC, Kano Y.

J Appl Physiol (1985). 2018 Jul 1;125(1):134-145. doi: 10.1152/japplphysiol.00972.2017. Epub 2018 Mar 22.

PMID:
29565774
13.

Prevalence of ESBL/AmpC genes and specific clones among the third-generation cephalosporin-resistant Enterobacteriaceae from canine and feline clinical specimens in Japan.

Maeyama Y, Taniguchi Y, Hayashi W, Ohsaki Y, Osaka S, Koide S, Tamai K, Nagano Y, Arakawa Y, Nagano N.

Vet Microbiol. 2018 Mar;216:183-189. doi: 10.1016/j.vetmic.2018.02.020. Epub 2018 Feb 16.

PMID:
29519514
14.

Genetic shifts in methicillin-resistant Staphylococcus aureus epidemic clones and toxin gene profiles in Japan: comparative analysis among pre-epidemic, epidemic and post-epidemic phases.

Osaka S, Okuzumi K, Koide S, Tamai K, Sato T, Tanimoto K, Tomita H, Suzuki M, Nagano Y, Shibayama K, Arakawa Y, Nagano N.

J Med Microbiol. 2018 Mar;67(3):392-399. doi: 10.1099/jmm.0.000687. Epub 2018 Feb 2.

PMID:
29458554
15.

First report of colistin resistance in OXA-181 carbapenemase-producing Klebsiella pneumoniae ST3130 in Japan.

Hayashi W, Togashi M, Taniguchi Y, Koide S, Nagano Y, Nagano N.

J Glob Antimicrob Resist. 2018 Mar;12:179-180. doi: 10.1016/j.jgar.2018.01.020. Epub 2018 Feb 4. No abstract available.

PMID:
29414724
16.
17.

Atomic structure of the eukaryotic intramembrane RAS methyltransferase ICMT.

Diver MM, Pedi L, Koide A, Koide S, Long SB.

Nature. 2018 Jan 25;553(7689):526-529. doi: 10.1038/nature25439. Epub 2018 Jan 17.

18.

Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms.

Ueda K, Ikeda K, Ikezoe T, Harada-Shirado K, Ogawa K, Hashimoto Y, Sano T, Ohkawara H, Kimura S, Shichishima-Nakamura A, Nakamura Y, Shikama Y, Mori T, Mason PJ, Bessler M, Morishita S, Komatsu N, Shide K, Shimoda K, Koide S, Aoyama K, Oshima M, Iwama A, Takeishi Y.

Blood Adv. 2017 Jun 14;1(15):1001-1015. doi: 10.1182/bloodadvances.2017004457. eCollection 2017 Jun 27.

19.

Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase.

Reckel S, Gehin C, Tardivon D, Georgeon S, Kükenshöner T, Löhr F, Koide A, Buchner L, Panjkovich A, Reynaud A, Pinho S, Gerig B, Svergun D, Pojer F, Güntert P, Dötsch V, Koide S, Gavin AC, Hantschel O.

Nat Commun. 2017 Dec 13;8(1):2101. doi: 10.1038/s41467-017-02313-6.

20.

MASTDISCS combi Carba plus, a simple method for discriminating carbapenemase-producing Enterobacteriaceae, including OXA-48-type producers.

Ohsaki Y, Kubo R, Hobson J, Davies M, Osaka S, Hayashi W, Taniguchi Y, Koide S, Nagano Y, Nagano N.

Microbiol Immunol. 2018 Jan;62(1):60-65. doi: 10.1111/1348-0421.12553.

PMID:
29115680
21.

A synthetic intrabody-based selective and generic inhibitor of GPCR endocytosis.

Ghosh E, Srivastava A, Baidya M, Kumari P, Dwivedi H, Nidhi K, Ranjan R, Dogra S, Koide A, Yadav PN, Sidhu SS, Koide S, Shukla AK.

Nat Nanotechnol. 2017 Dec;12(12):1190-1198. doi: 10.1038/nnano.2017.188. Epub 2017 Oct 2.

22.

Co-resistance to colistin and tigecycline by disrupting mgrB and ramR with IS insertions in a canine Klebsiella pneumoniae ST37 isolate producing SHV-12, DHA-1 and FosA3.

Taniguchi Y, Maeyama Y, Ohsaki Y, Hayashi W, Osaka S, Koide S, Tamai K, Nagano Y, Arakawa Y, Nagano N.

Int J Antimicrob Agents. 2017 Nov;50(5):697-698. doi: 10.1016/j.ijantimicag.2017.09.011. Epub 2017 Sep 21. No abstract available.

PMID:
28943368
23.

Stachel-independent modulation of GPR56/ADGRG1 signaling by synthetic ligands directed to its extracellular region.

Salzman GS, Zhang S, Gupta A, Koide A, Koide S, Araç D.

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10095-10100. doi: 10.1073/pnas.1708810114. Epub 2017 Sep 5.

24.

Prognostic Value of the CHADS2 Score for Adverse Cardiovascular Events in Coronary Artery Disease Patients Without Atrial Fibrillation-A Multi-Center Observational Cohort Study.

Tabata N, Yamamoto E, Hokimoto S, Yamashita T, Sueta D, Takashio S, Arima Y, Izumiya Y, Kojima S, Kaikita K, Matsui K, Fujimoto K, Sakamoto K, Shimomura H, Tsunoda R, Hirose T, Nakamura N, Sakaino N, Nakamura S, Yamamoto N, Matsumura T, Kajiwara I, Koide S, Sakamoto T, Nakao K, Oshima S, Tsujita K; Kumamoto Intervention Conference Study (KICS) Investigators.

J Am Heart Assoc. 2017 Aug 16;6(8). pii: e006355. doi: 10.1161/JAHA.117.006355.

25.

Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies.

Tanaka T, Nakajima-Takagi Y, Aoyama K, Tara S, Oshima M, Saraya A, Koide S, Si S, Manabe I, Sanada M, Nakayama M, Masuko M, Sone H, Koseki H, Iwama A.

J Exp Med. 2017 Oct 2;214(10):2901-2913. doi: 10.1084/jem.20170167. Epub 2017 Aug 21.

26.

Ratio of blood urea nitrogen to serum creatinine at initiation of dialysis is associated with mortality: a multicenter prospective cohort study.

Inaguma D, Koide S, Ito E, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y; AICOPP group.

Clin Exp Nephrol. 2018 Apr;22(2):353-364. doi: 10.1007/s10157-017-1458-x. Epub 2017 Aug 1.

PMID:
28766029
27.

Targeting the α4-α5 interface of RAS results in multiple levels of inhibition.

Spencer-Smith R, Li L, Prasad S, Koide A, Koide S, O'Bryan JP.

Small GTPases. 2017 Jul 10:1-10. doi: 10.1080/21541248.2017.1333188. [Epub ahead of print]

PMID:
28692342
28.

First Detection of an Escherichia coli Strain Harboring the mcr-1 Gene in Retail Domestic Chicken Meat in Japan.

Ohsaki Y, Hayashi W, Saito S, Osaka S, Taniguchi Y, Koide S, Kawamura K, Nagano Y, Arakawa Y, Nagano N.

Jpn J Infect Dis. 2017 Sep 25;70(5):590-592. doi: 10.7883/yoken.JJID.2016.572. Epub 2017 Jul 1.

29.

Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.

Rizq O, Mimura N, Oshima M, Saraya A, Koide S, Kato Y, Aoyama K, Nakajima-Takagi Y, Wang C, Chiba T, Ma A, Jin J, Iseki T, Nakaseko C, Iwama A.

Clin Cancer Res. 2017 Aug 15;23(16):4817-4830. doi: 10.1158/1078-0432.CCR-16-2735. Epub 2017 May 10.

PMID:
28490465
30.

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.

Yokoyama M, Chiba T, Zen Y, Oshima M, Kusakabe Y, Noguchi Y, Yuki K, Koide S, Tara S, Saraya A, Aoyama K, Mimura N, Miyagi S, Inoue M, Wakamatsu T, Saito T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Otsuka M, Miyazaki M, Yokosuka O, Iwama A.

Oncotarget. 2017 Mar 28;8(13):21315-21326. doi: 10.18632/oncotarget.15528.

31.

Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody.

Rizk SS, Mukherjee S, Koide A, Koide S, Kossiakoff AA.

Sci Rep. 2017 Apr 3;7(1):556. doi: 10.1038/s41598-017-00728-1.

32.

Selective Targeting of SH2 Domain-Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.

Kükenshöner T, Schmit NE, Bouda E, Sha F, Pojer F, Koide A, Seeliger M, Koide S, Hantschel O.

J Mol Biol. 2017 May 5;429(9):1364-1380. doi: 10.1016/j.jmb.2017.03.023. Epub 2017 Mar 25.

33.

Association between resting heart rate just before starting the first dialysis session and mortality: A multicentre prospective cohort study.

Inaguma D, Koide S, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y; AICOPP group.

Nephrology (Carlton). 2018 May;23(5):461-468. doi: 10.1111/nep.13048.

PMID:
28332737
34.

Monobodies and other synthetic binding proteins for expanding protein science.

Sha F, Salzman G, Gupta A, Koide S.

Protein Sci. 2017 May;26(5):910-924. doi: 10.1002/pro.3148. Epub 2017 Mar 24. Review.

35.
36.

sNASP and ASF1A function through both competitive and compatible modes of histone binding.

Bowman A, Koide A, Goodman JS, Colling ME, Zinne D, Koide S, Ladurner AG.

Nucleic Acids Res. 2017 Jan 25;45(2):643-656. doi: 10.1093/nar/gkw892. Epub 2016 Oct 5.

37.

Inhibition of RAS function through targeting an allosteric regulatory site.

Spencer-Smith R, Koide A, Zhou Y, Eguchi RR, Sha F, Gajwani P, Santana D, Gupta A, Jacobs M, Herrero-Garcia E, Cobbert J, Lavoie H, Smith M, Rajakulendran T, Dowdell E, Okur MN, Dementieva I, Sicheri F, Therrien M, Hancock JF, Ikura M, Koide S, O'Bryan JP.

Nat Chem Biol. 2017 Jan;13(1):62-68. doi: 10.1038/nchembio.2231. Epub 2016 Nov 7.

38.

The Level of IgA Antibodies to Endothelial Cells Correlates with Histological Evidence of Disease Activity in Patients with Lupus Nephritis.

Kondo A, Takahashi K, Mizuno T, Kato A, Hirano D, Yamamoto N, Hayashi H, Koide S, Takahashi H, Hasegawa M, Hiki Y, Yoshida S, Miura K, Yuzawa Y.

PLoS One. 2016 Oct 27;11(10):e0163085. doi: 10.1371/journal.pone.0163085. eCollection 2016.

39.

Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia.

Shimizu R, Muto T, Aoyama K, Choi K, Takeuchi M, Koide S, Hasegawa N, Isshiki Y, Togasaki E, Kawajiri-Manako C, Nagao Y, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Ohwada C, Sakaida E, Iseki T, Starczynowski DT, Iwama A, Yokote K, Nakaseko C.

Leuk Res. 2016 Nov;50:85-94. doi: 10.1016/j.leukres.2016.09.018. Epub 2016 Sep 26.

40.

Impact of combinatorial dysfunctions of Tet2 and Ezh2 on the epigenome in the pathogenesis of myelodysplastic syndrome.

Hasegawa N, Oshima M, Sashida G, Matsui H, Koide S, Saraya A, Wang C, Muto T, Takane K, Kaneda A, Shimoda K, Nakaseko C, Yokote K, Iwama A.

Leukemia. 2017 Apr;31(4):861-871. doi: 10.1038/leu.2016.268. Epub 2016 Oct 3.

PMID:
27694924
41.

Aromatic claw: A new fold with high aromatic content that evades structural prediction.

Sachleben JR, Adhikari AN, Gawlak G, Hoey RJ, Liu G, Joachimiak A, Montelione GT, Sosnick TR, Koide S.

Protein Sci. 2017 Feb;26(2):208-217. doi: 10.1002/pro.3069. Epub 2016 Nov 10.

42.

Structural Basis for Regulation of GPR56/ADGRG1 by Its Alternatively Spliced Extracellular Domains.

Salzman GS, Ackerman SD, Ding C, Koide A, Leon K, Luo R, Stoveken HM, Fernandez CG, Tall GG, Piao X, Monk KR, Koide S, Araç D.

Neuron. 2016 Sep 21;91(6):1292-1304. doi: 10.1016/j.neuron.2016.08.022.

43.

Specific Recognition of a Single-Stranded RNA Sequence by a Synthetic Antibody Fragment.

Shao Y, Huang H, Qin D, Li NS, Koide A, Staley JP, Koide S, Kossiakoff AA, Piccirilli JA.

J Mol Biol. 2016 Oct 9;428(20):4100-4114. doi: 10.1016/j.jmb.2016.08.029. Epub 2016 Sep 2.

44.

Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: Subanalysis of PRECISE-IVUS trial.

Tsujita K, Yamanaga K, Komura N, Sakamoto K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE-IVUS Investigators.

Atherosclerosis. 2016 Aug;251:367-372. doi: 10.1016/j.atherosclerosis.2016.05.025. Epub 2016 May 20.

PMID:
27318866
45.

Setdb1 maintains hematopoietic stem and progenitor cells by restricting the ectopic activation of nonhematopoietic genes.

Koide S, Oshima M, Takubo K, Yamazaki S, Nitta E, Saraya A, Aoyama K, Kato Y, Miyagi S, Nakajima-Takagi Y, Chiba T, Matsui H, Arai F, Suzuki Y, Kimura H, Nakauchi H, Suda T, Shinkai Y, Iwama A.

Blood. 2016 Aug 4;128(5):638-49. doi: 10.1182/blood-2016-01-694810. Epub 2016 Jun 14.

46.

Synergistic effect of ezetimibe addition on coronary atheroma regression in patients with prior statin therapy: Subanalysis of PRECISE-IVUS trial.

Tsujita K, Yamanaga K, Komura N, Sakamoto K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE-IVUS Investigators.

Eur J Prev Cardiol. 2016 Sep;23(14):1524-8. doi: 10.1177/2047487316655465. Epub 2016 Jun 13.

PMID:
27296705
47.

Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.

Morimoto M, Matsuo Y, Koide S, Tsuboi K, Shamoto T, Sato T, Saito K, Takahashi H, Takeyama H.

BMC Cancer. 2016 May 12;16:305. doi: 10.1186/s12885-016-2340-z.

48.

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Cardiovascular Events in Patients with Chronic Kidney Disease.

Hasegawa M, Ishii J, Kitagawa F, Takahashi H, Sugiyama K, Tada M, Kanayama K, Takahashi K, Hayashi H, Koide S, Nakai S, Ozaki Y, Yuzawa Y.

Biomed Res Int. 2016;2016:8761475. doi: 10.1155/2016/8761475. Epub 2016 Mar 14.

49.

Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.

Kurimoto R, Iwasawa S, Ebata T, Ishiwata T, Sekine I, Tada Y, Tatsumi K, Koide S, Iwama A, Takiguchi Y.

Int J Oncol. 2016 May;48(5):1825-36. doi: 10.3892/ijo.2016.3419. Epub 2016 Mar 4.

50.

Clinical outcomes of percutaneous coronary intervention for acute coronary syndrome between hospitals with and without onsite cardiac surgery backup.

Akasaka T, Hokimoto S, Sueta D, Tabata N, Oshima S, Nakao K, Fujimoto K, Miyao Y, Shimomura H, Tsunoda R, Hirose T, Kajiwara I, Matsumura T, Nakamura N, Yamamoto N, Koide S, Nakamura S, Morikami Y, Sakaino N, Kaikita K, Nakamura S, Matsui K, Ogawa H; Kumamoto Intervention Conference Study (KICS) Investigators.

J Cardiol. 2017 Jan;69(1):103-109. doi: 10.1016/j.jjcc.2016.01.012. Epub 2016 Feb 23.

Supplemental Content

Support Center